Pfizer to invest $350 million in China biotech hub, first in Asia
The facility in eastern Hangzhou region - Pfizer's first biotech centre in Asia - is expected to be completed by 2018.28-06-2016
28-06-2016
Pharma biggies like Cipla, Pfizer among 200 under lens for poor drugs
According to a source, notices have been issued recently to Cipla and Pfizer informing them of the upcoming inspection as well as violations found in their products.21-06-2016
Intimation of Schedule of Analyst / Institutional Investor Meetings
Pfizer Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".15-06-2016
Fixes Book Closure for Dividend & AGM (Cut-off date for e-voting)
Pfizer Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from June 29, 2016 to July 05, 2016 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on July 05, 2016.13-06-2016
Intimation of Schedule of Analyst / Institutional Investor Meetings
Pfizer Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".20-05-2016
Intimation of Schedule of Analyst / Institutional Investor Meetings
Pfizer Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".19-05-2016
Novartis breast cancer drug set to take on Pfizer's Ibrance, assuming 2018 launch
The lab testing was stopped early because of its good results, plans to divide the pharmaceutical division in two unit,one focusing only on cancer drugs.18-05-2016
Pfizer to buy Anacor Pharma in $5.2 billion deal
The deal will give Pfizer access to Anacor's non-steroidal topical gel to treat eczema16-05-2016
Piramal Enterprises buys four Pfizer brands for Rs110 crore
The acquired brands, Ferradol, Neko, Sloan's and Waterbury's Compound, have a collective market size of approximately Rs7,000 crore13-05-2016
Sale of Four Product to Piramal Enterprises Limited
Pfizer Ltd has informed BSE that the Company has entered into an agreement with Piramal Enterprises Limited for sale of its 4 products viz., Neko Soap, Sloans, Ferradol and Waterbury's Compound for a total consideration of Rs. 110 Crores, subject to adjustments for inventory on closing and transaction costs.In this regard, the Company has issued the Press note.13-05-2016